Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA subpopulations

Guardado en:
Detalles Bibliográficos
Publicado en:Nature Communications vol. 16, no. 1 (2025), p. 10460-10475
Autor principal: Zhou, Sihang
Otros Autores: Lizarazo, Simon, Chorghade, Sandip, Mouli, Leela, Cheng, Ruiying, K C, Rajendra, Kalsotra, Auinash, Van Bortle, Kevin
Publicado:
Nature Publishing Group
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3275619782
003 UK-CbPIL
022 |a 2041-1723 
024 7 |a 10.1038/s41467-025-65448-x  |2 doi 
035 |a 3275619782 
045 2 |b d20250101  |b d20251231 
084 |a 145839  |2 nlm 
100 1 |a Zhou, Sihang  |u Department of Cell and Developmental Biology, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991) 
245 1 |a Cancer-associated snaR-A noncoding RNA interacts with core splicing machinery and disrupts processing of mRNA subpopulations 
260 |b Nature Publishing Group  |c 2025 
513 |a Journal Article 
520 3 |a Expansion of RNA polymerase III (Pol III) activity in cancer can activate the transcription of typically silent small RNA genes, including snaR-A (small NF90-associated RNA isoform A), a hominid-specific noncoding RNA that promotes cell proliferation through unclear mechanisms. Here, we show that snaR-A interacts with mRNA splicing factors, including the U2 small nuclear ribonucleoprotein (snRNP) subunit SF3B2, and localizes near subnuclear foci enriched in splicing machinery. Overexpression of snaR-A increases intron retention, a hallmark of inefficient splicing, whereas its depletion enhances splicing of mRNAs characterized by high U2 snRNP occupancy and nuclear speckle proximity. These improvements in splicing coincide with reduced cell proliferation, consistent with tumor-level patterns linking snaR-A to growth in primary cancers. Together, these findings identify snaR-A as a molecular antagonist of splicing and potential disease driver in cancer. We propose that snaR-A-related splicing perturbation may phenocopy splicing defects attributed to U2 snRNP mutations in cancer, eliciting an alternative, non-mutational mechanism of splicing dysregulation during tumorigenesis.Small RNAs such as snaR-A (small NF90-associated RNA isoform A) may contribute to cancer-related phenotypes. Here the authors find that snaR-A interacts with mRNA splicing factors in subnuclear foci and causes splicing defects in mRNA subpopulations, which is associated with increased cell proliferation, and poor outcomes in cancer patients. 
653 |a Cancer 
653 |a Ribonucleoproteins (U2 small nuclear) 
653 |a Ontology 
653 |a Experiments 
653 |a Ribonucleoproteins (small nuclear) 
653 |a Ribonucleic acid--RNA 
653 |a Phenotypes 
653 |a Cell proliferation 
653 |a Alternative splicing 
653 |a RNA-protein interactions 
653 |a Hybridization 
653 |a Tumorigenesis 
653 |a Splicing factors 
653 |a Non-coding RNA 
653 |a Localization 
653 |a Genes 
653 |a Cell growth 
653 |a Defects 
653 |a DNA-directed RNA polymerase 
653 |a Subpopulations 
653 |a Environmental 
700 1 |a Lizarazo, Simon  |u Department of Molecular and Integrative Physiology, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991) 
700 1 |a Chorghade, Sandip  |u Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991) 
700 1 |a Mouli, Leela  |u School of Molecular and Cellular Biology, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991) 
700 1 |a Cheng, Ruiying  |u Department of Cell and Developmental Biology, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991) 
700 1 |a K C, Rajendra  |u Center for Biophysics and Quantitative Biology, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991) 
700 1 |a Kalsotra, Auinash  |u Department of Biochemistry, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991); Cancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991); Carl R. Woese Institute for Genomic Biology, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991); Chan Zuckerberg Biohub Chicago, LLC, Chicago, IL, USA 
700 1 |a Van Bortle, Kevin  |u Department of Cell and Developmental Biology, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991); Cancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, IL, USA (ROR: https://ror.org/047426m28) (GRID: grid.35403.31) (ISNI: 0000 0004 1936 9991) 
773 0 |t Nature Communications  |g vol. 16, no. 1 (2025), p. 10460-10475 
786 0 |d ProQuest  |t Health & Medical Collection 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3275619782/abstract/embedded/75I98GEZK8WCJMPQ?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3275619782/fulltext/embedded/75I98GEZK8WCJMPQ?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3275619782/fulltextPDF/embedded/75I98GEZK8WCJMPQ?source=fedsrch